AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26657482 — intervention group
Group type: COMPARATOR
Intervention: Rinsing with fluoride mouthwash (0.05% NaF; 226-ppm fluoride)
Number of subjects: 21
Study 24639426 — intervention group
Group type: EXPERIMENTAL
Intervention: dalcetrapib 600 mg/day
Number of subjects: 300
Study 24639426 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 300
Study 22613230 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluid reasoning task (fMRI data collected)
Number of subjects: 22
Study 20676928 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer navigator intervention
Number of subjects: 176
Study 20676928 — intervention group
Group type: COMPARATOR
Intervention: Usual care control arm
Number of subjects: 176
Study 17389338 — intervention group
Group type: EXPERIMENTAL
Intervention: Fludarabine (25 mg/m2/d for 5 days IV, repeated every 28 days)
Number of subjects: 375
Study 17389338 — intervention group
Group type: COMPARATOR
Intervention: Fludarabine plus cyclophosphamide (FC) (fludarabine 30 mg/m2/d for 3 days IV plus cyclophosphamide 250 mg/m2/d for 3 days, repeated every 28 days)
Number of subjects: 375
Study 16344188 — intervention group
Group type: EXPERIMENTAL
Intervention: Sutter implant replacement arthroplasty
Number of subjects: 45
Study 16344188 — intervention group
Group type: COMPARATOR
Intervention: Swanson implant replacement arthroplasty
Number of subjects: 45
Study 16344188 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Sutter and Swanson)
Number of subjects: 45
Study 16540800 — intervention group
Group type: EXPERIMENTAL
Intervention: MMN (iron 12.5 mg + folic acid 150 microg + zinc 5 mg)
Number of subjects: 204
Study 16540800 — intervention group
Group type: EXPERIMENTAL
Intervention: FFA (iron 12.5 mg + folic acid 150 microg)
Number of subjects: 204
Study 16540800 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 204
Study 16540800 — intervention group
Group type: EXPERIMENTAL
Intervention: MMN and FFA
Number of subjects: 204
Study 11022872 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 18
Study 11022872 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbonated, non-caffeinated, citrus soft drink
Number of subjects: 18
Study 11022872 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeinated caloric and non-caloric colas and coffee
Number of subjects: 18
Study 8878221 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral vitamin A (50,000 to 200,000 IU of retinyl palmitate, doses according to age; n = 89)
Number of subjects: 180
Study 8878221 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 91)
Number of subjects: 180
Study 8878221 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral vitamin A (for subgroup with significant hypoxemia)
Number of subjects: 180
Study 1512341 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide and amiloride (50 + 5 mg)
Number of subjects: 22
Study 1512341 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 1512341 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal nitroglycerin (19 +/- 1 mg/24 h)
Number of subjects: 22
Study 1512341 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual nitroglycerin (0.6 mg)
Number of subjects: 22
Study 6421013 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin 50 mg three times a day for 1 week
Number of subjects: 6
Study 6421013 — intervention group
Group type: COMPARATOR
Intervention: Placebo three times a day for 1 week
Number of subjects: 6
Study 29966038 — intervention group
Group type: EXPERIMENTAL
Intervention: Roxadustat (100 mg) under fed conditions
Number of subjects: 16
Study 29966038 — intervention group
Group type: COMPARATOR
Intervention: Roxadustat (100 mg) under fasted conditions
Number of subjects: 16
Study 29966038 — intervention group
Group type: EXPERIMENTAL
Intervention: Roxadustat (100 mg) with SCA
Number of subjects: 16
Study 29966038 — intervention group
Group type: COMPARATOR
Intervention: Roxadustat (100 mg) alone
Number of subjects: 16
Study 30358565 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard dose oseltamivir (SD)
Number of subjects: 44
Study 30358565 — intervention group
Group type: EXPERIMENTAL
Intervention: Double dose oseltamivir (DD)
Number of subjects: 44
Study 27041244 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg/day rosuvastatin (R group, n=26)
Number of subjects: 50
Study 27041244 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg/day rosuvastatin plus 2 g/day of ω-3 PUFAs (R+O group, n=24)
Number of subjects: 50
Study 27041244 — intervention group
Group type: COMPARATOR
Intervention: Control group (55 normolipidaemic subjects)
Number of subjects: 50
Study 24928218 — intervention group
Group type: EXPERIMENTAL
Intervention: Directly observed varenicline therapy
Number of subjects: 100
Study 24928218 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (self-administered varenicline)
Number of subjects: 100
Study 22010847 — intervention group
Group type: EXPERIMENTAL
Intervention: Agaricus blazei Murrill (AbM) dry extract, 900 mg/day for 60 days
Number of subjects: 57
Study 22010847 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study 20467879 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous dexmedetomidine administered for 60 min
Number of subjects: 60
Study 20467879 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous dexmedetomidine
Number of subjects: 60
Study 20467879 — intervention group
Group type: COMPARATOR
Intervention: Physiological saline (control)
Number of subjects: 60
Study 17880478 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation programme
Number of subjects: 167
Study 17880478 — intervention group
Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 167
Study 16583593 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% benzocaine gel
Number of subjects: 30
Study 16583593 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 11834101 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training program (10 weeks, 8 exercises for the entire body, no flexibility exercises)
Number of subjects: 19
Study 11834101 — intervention group
Group type: COMPARATOR
Intervention: Control group (physically inactive women aged 62 to 73 years)
Number of subjects: 19
Study 10402248 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuroendocrine tumors (carcinoids)
Number of subjects: 25
Study 8626261 — intervention group
Group type: EXPERIMENTAL
Intervention: Once daily dosing (6 mg/kg)
Number of subjects: 113
Study 8626261 — intervention group
Group type: COMPARATOR
Intervention: Thrice daily dosing (6 mg/kg)
Number of subjects: 113
Study 31434765 — intervention group
Group type: EXPERIMENTAL
Intervention: Ion-exchange water softener installed prior to birth
Number of subjects: 80
Study 31434765 — intervention group
Group type: COMPARATOR
Intervention: Usual domestic hard water supply
Number of subjects: 80
Study 29179666 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic liver resection
Number of subjects: 40
Study 29179666 — intervention group
Group type: COMPARATOR
Intervention: Open liver resection
Number of subjects: 40
Study 26921496 — intervention group
Group type: EXPERIMENTAL
Intervention: Shuangbai San
Number of subjects: 134
Study 26921496 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 134
Study 24828621 — intervention group
Group type: EXPERIMENTAL
Intervention: Interprofessional care team including a physician, nurse practitioner, clinical pharmacist, and students
Number of subjects: 0
Study 22986336 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg cortisol
Number of subjects: 122
Study 22986336 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 122
Study 19442259 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg daily
Number of subjects: 20536
Study 17313268 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive functional training program (8 weeks)
Number of subjects: 18
Study 17313268 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 18
Study 15353142 — intervention group
Group type: EXPERIMENTAL
Intervention: Norethisterone oenanthate (NET EN) 200 mg used as a 2‐monthly injection
Number of subjects: 50
Study 15353142 — intervention group
Group type: COMPARATOR
Intervention: Control group (not using any hormonal contraception)
Number of subjects: 50
Study 11303833 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotavirus vaccination
Number of subjects: 1432
Study 11303833 — intervention group
Group type: COMPARATOR
Intervention: Placebo vaccination
Number of subjects: 1432
Study 9599191 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein supplementation, 20 g/d
Number of subjects: 82
Study 9599191 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric placebo
Number of subjects: 82
Study 8023348 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimodipine 120 mg/d PO for 21 days
Number of subjects: 350
Study 8023348 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 350
Study 2661606 — intervention group
Group type: EXPERIMENTAL
Intervention: Benztropine 4 mg/day
Number of subjects: 60
Study 2661606 — intervention group
Group type: COMPARATOR
Intervention: Amantadine 200 mg/day
Number of subjects: 60
Study 1229217 — intervention group
Group type: EXPERIMENTAL
Intervention: Desoximetason (0.25%)
Number of subjects: 44
Study 1229217 — intervention group
Group type: COMPARATOR
Intervention: Betamethasone‐valerate (0.1%)
Number of subjects: 44
Study 31006864 — intervention group
Group type: EXPERIMENTAL
Intervention: Prosthetic suture repair technique
Number of subjects: 18
Study 31006864 — intervention group
Group type: COMPARATOR
Intervention: Medial injury
Number of subjects: 18
Study 31006864 — intervention group
Group type: COMPARATOR
Intervention: Lateral injury
Number of subjects: 18
Study 31006864 — intervention group
Group type: COMPARATOR
Intervention: Bilateral injury
Number of subjects: 18
Study 28988240 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive 1-year lifestyle treatment with 2 months inpatient period (short-stay group)
Number of subjects: 80
Study 28988240 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive 1-year lifestyle treatment with 6 months inpatient period (long-stay group)
Number of subjects: 80
Study 28988240 — intervention group
Group type: COMPARATOR
Intervention: Short-stay treatment
Number of subjects: 80
Study 28988240 — intervention group
Group type: COMPARATOR
Intervention: Long-stay treatment
Number of subjects: 80
Study 25213082 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio Taping (KT)
Number of subjects: 30
Study 24076103 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine digluconate solution applied for 30s after etching
Number of subjects: 70
Study 24076103 — intervention group
Group type: COMPARATOR
Intervention: Control group restored with Adper Single Bond 2
Number of subjects: 70
Study 21518686 — intervention group
Group type: EXPERIMENTAL
Intervention: RenalGuard System treatment
Number of subjects: 0
Study 21518686 — intervention group
Group type: COMPARATOR
Intervention: Sodium bicarbonate plus N-acetylcysteine (NAC)
Number of subjects: 0
Study 18356834 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard group-based behavioral treatment
Number of subjects: 76
Study 17112307 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous droperidol
Number of subjects: 0
Study 15153824 — intervention group
Group type: EXPERIMENTAL
Intervention: Firm inelastic bandages
Number of subjects: 53
Study 15153824 — intervention group
Group type: EXPERIMENTAL
Intervention: Elastic compression stockings
Number of subjects: 53
Study 15153824 — intervention group
Group type: COMPARATOR
Intervention: Bed rest without any compression
Number of subjects: 53
Study 15153824 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression (both bandages and stockings)
Number of subjects: 53
Study 10765075 — intervention group
Group type: EXPERIMENTAL
Intervention: Color and power Doppler ultrasound
Number of subjects: 39
Study 8618770 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.02% (0.2 mg/ml) mitomycin C for 5 minutes
Number of subjects: 81
Study 8618770 — intervention group
Group type: COMPARATOR
Intervention: NaCl 0.9%
Number of subjects: 81
Study 1451240 — intervention group
Group type: EXPERIMENTAL
Intervention: Interposed abdominal compression-CPR
Number of subjects: 143
Study 1451240 — intervention group
Group type: COMPARATOR
Intervention: Standard CPR
Number of subjects: 143
Study 6398861 — intervention group
Group type: EXPERIMENTAL
Intervention: Halopemide (2 X 10 mg/day)
Number of subjects: 20
Study 6398861 — intervention group
Group type: EXPERIMENTAL
Intervention: Halopemide (2 X 20 mg/day)
Number of subjects: 20
Study 6398861 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 29731160 — intervention group
Group type: EXPERIMENTAL
Intervention: T2w intensity maps
Number of subjects: 260
Study 29731160 — intervention group
Group type: EXPERIMENTAL
Intervention: ADC intensity maps
Number of subjects: 260
Study 29731160 — intervention group
Group type: EXPERIMENTAL
Intervention: Ktrans intensity maps
Number of subjects: 260
Study 29731160 — intervention group
Group type: EXPERIMENTAL
Intervention: AUC analysis
Number of subjects: 260
Study 26774919 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorescence lymphangiography with indocyanine green (ICG) (50 μl, 0.05%w/v)
Number of subjects: 0
Study 26774919 — intervention group
Group type: EXPERIMENTAL
Intervention: External uniaxial loading (60 mmHg for 45 min)
Number of subjects: 0
Study 23859303 — intervention group
Group type: EXPERIMENTAL
Intervention: amlodipine/benazepril 2.5/10 mg
Number of subjects: 341
Study 23859303 — intervention group
Group type: EXPERIMENTAL
Intervention: amlodipine/benazepril 5/10 mg
Number of subjects: 341
Study 23859303 — intervention group
Group type: COMPARATOR
Intervention: benazepril 10 mg
Number of subjects: 341
Study 22776441 — intervention group
Group type: EXPERIMENTAL
Intervention: Familias Unidas
Number of subjects: 242
Study 22776441 — intervention group
Group type: COMPARATOR
Intervention: Community Practice
Number of subjects: 242
Study 20667269 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants who made between 5 and 12 mistakes
Number of subjects: 188
Study 18590110 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple therapy (methotrexate + sulfasalazine + hydroxychloroquine)
Number of subjects: 60
Study 18590110 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate monotherapy
Number of subjects: 60
Study 15279353 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard anatrophic nephrolithotomy (sANL)
Number of subjects: 15
Study 15279353 — intervention group
Group type: COMPARATOR
Intervention: Modified anatrophic nephrolithotomy (mANL)
Number of subjects: 15
Study 12241634 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial median and ulnar nerve transfer; specific details on dosage and duration not available.
Number of subjects: 23
Study 12241634 — intervention group
Group type: COMPARATOR
Intervention: Phrenic and spinal accessary nerve transfer; specific details on dosage and duration not available.
Number of subjects: 23
Study 9649906 — intervention group
Group type: EXPERIMENTAL
Intervention: 0‐Ex (flat surface)
Number of subjects: 10
Study 9649906 — intervention group
Group type: EXPERIMENTAL
Intervention: 12‐Ex (12% steady inclination)
Number of subjects: 10
Study 9649906 — intervention group
Group type: EXPERIMENTAL
Intervention: p‐Ex (progressively increasing inclination)
Number of subjects: 10
Study 9649906 — intervention group
Group type: COMPARATOR
Intervention: Treadmill exercise testing
Number of subjects: 10
Study 9649906 — intervention group
Group type: EXPERIMENTAL
Intervention: Graded exercise
Number of subjects: 10
Study 9649906 — intervention group
Group type: EXPERIMENTAL
Intervention: ABI after exercise
Number of subjects: 10
Study 8087937 — intervention group
Group type: EXPERIMENTAL
Intervention: ATP‐MgCl2 (0.1 mg/kg/min)
Number of subjects: 35
Study 8087937 — intervention group
Group type: COMPARATOR
Intervention: Tolazoline (1 mg/kg)
Number of subjects: 35
Study 8087937 — intervention group
Group type: EXPERIMENTAL
Intervention: ATP‐MgCl2 (after surgery)
Number of subjects: 35
Study 2503148 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy (1320 to 1510 rets) after simple mastectomy
Number of subjects: 2800
Study 2503148 — intervention group
Group type: COMPARATOR
Intervention: Careful observation of the axilla after simple mastectomy (control group)
Number of subjects: 2800
Study 2503148 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy (for left breast tumors)
Number of subjects: 2800
Study 2503148 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy (orthovoltage treatment)
Number of subjects: 2800
Study 2503148 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy (after five years)
Number of subjects: 2800
Study 2503148 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy (for left breast tumors with orthovoltage)
Number of subjects: 2800
Study 361132 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG immunotherapy as an adjunct to surgery
Number of subjects: 0
Study 361132 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone (control)
Number of subjects: 0
Study 31779056 — intervention group
Group type: EXPERIMENTAL
Intervention: Full dose of quadrivalent influenza vaccine
Number of subjects: 124
Study 31779056 — intervention group
Group type: COMPARATOR
Intervention: Half dose of trivalent influenza vaccine
Number of subjects: 124
Study 29851024 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mL/kg Ringer's acetate solution before the induction of anaesthesia
Number of subjects: 219
Study 29851024 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (control group)
Number of subjects: 219
Study 29851024 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 219
Study 29851024 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 219
Study 26293163 — intervention group
Group type: EXPERIMENTAL
Intervention: Tabalumab 120 mg every 2 weeks (120 Q2W)
Number of subjects: 1124
Study 26293163 — intervention group
Group type: EXPERIMENTAL
Intervention: Tabalumab 120 mg every 4 weeks (120 Q4W)
Number of subjects: 1124
Study 26293163 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1124
Study 25268295 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3
Number of subjects: 492
Study 25268295 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 492
Study 25268295 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (severe deficiency subgroup)
Number of subjects: 492
Study 25268295 — intervention group
Group type: COMPARATOR
Intervention: Placebo (severe deficiency subgroup)
Number of subjects: 492
Study 22961832 — intervention group
Group type: COMPARATOR
Intervention: Chlorthalidone (active control)
Number of subjects: 42418
Study 22961832 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 42418
Study 22961832 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril
Number of subjects: 42418
Study 22961832 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxazosin
Number of subjects: 42418
Study 22961832 — intervention group
Group type: EXPERIMENTAL
Intervention: All agents
Number of subjects: 42418
Study 20444778 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer tutored problem‐based learning
Number of subjects: 142
Study 20444778 — intervention group
Group type: COMPARATOR
Intervention: Conventional teaching
Number of subjects: 142
Study 18559291 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine 60-120 mg/day
Number of subjects: 887
Study 18559291 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 887
Study 16024023 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate exercise (90-min treadmill walk)
Number of subjects: 20
Study 12814447 — intervention group
Group type: EXPERIMENTAL
Intervention: Motilin
Number of subjects: 8
Study 12814447 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 10838001 — intervention group
Group type: EXPERIMENTAL
Intervention: Group rehabilitation (GR) including eight sessions plus one booster session, combining information and/or cognitive-behavioral techniques with physical training and relaxation, starting approximately 4 months after diagnosis.
Number of subjects: 132
Study 10838001 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnosis-specific group meetings
Number of subjects: 132
Study 8817823 — intervention group
Group type: EXPERIMENTAL
Intervention: Acellular pertussis vaccine
Number of subjects: 432
Study 8817823 — intervention group
Group type: COMPARATOR
Intervention: Whole cell pertussis vaccine
Number of subjects: 432
Study 1564540 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-arterial BCNU
Number of subjects: 448
Study 1564540 — intervention group
Group type: COMPARATOR
Intervention: Intravenous BCNU
Number of subjects: 448
Study 1564540 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous 5-fluorouracil
Number of subjects: 448
Study 3970647 — intervention group
Group type: EXPERIMENTAL
Intervention: Pindolol (dosage not specified)
Number of subjects: 0
Study 3970647 — intervention group
Group type: EXPERIMENTAL
Intervention: Pindolol
Number of subjects: 0
Study 3970647 — intervention group
Group type: EXPERIMENTAL
Intervention: Automatic indirect BP monitoring
Number of subjects: 0
Study 31199939 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothesis aware condition
Number of subjects: 84
Study 31199939 — intervention group
Group type: COMPARATOR
Intervention: Hypothesis unaware condition
Number of subjects: 84
Study 28994655 — intervention group
Group type: EXPERIMENTAL
Intervention: B‐SES (bioresorbable polymer‐based sirolimus‐eluting stent)
Number of subjects: 170
Study 28994655 — intervention group
Group type: COMPARATOR
Intervention: R‐ZES (durable polymer‐based zotarolimus‐eluting stent)
Number of subjects: 170
Study 28994655 — intervention group
Group type: EXPERIMENTAL
Intervention: B‐SES
Number of subjects: 170
Study 28994655 — intervention group
Group type: COMPARATOR
Intervention: R‐ZES
Number of subjects: 170
Study 27843418 — intervention group
Group type: COMPARATOR
Intervention: CHO ingestion at 15 g/h
Number of subjects: 7
Study 27843418 — intervention group
Group type: COMPARATOR
Intervention: CHO ingestion at 60 g/h
Number of subjects: 7
Study 27843418 — intervention group
Group type: COMPARATOR
Intervention: Control (amino-acid electrolyte)
Number of subjects: 7
Study 24238825 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical tranexamic acid (2 g)
Number of subjects: 100
Study 24238825 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100